Results 31 to 40 of about 229,492 (119)

Bilateral IgG4‐Related Dacryoadenitis

open access: yesClinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Chronic dacryoadenitis is an uncommon inflammation of the lacrimal gland that may have various etiologies with similar presentations. IgG4‐related ophthalmic disease most often manifests as painless lacrimal gland enlargement, so the clinicians should consider IgG4‐related disease as a diagnostic possibility for dacryoadenitis.
Yan Song, Lin Ding, Tao Shen
wiley   +1 more source

World thyroidology news

open access: yesКлиническая и экспериментальная тиреоидология, 2014
The article is to overview papers: Effect of vitamin C on the absorption of levothyroxine in patients with hypothyroidism and gastritis. Management of neonates born to women with Graves’ disease: a cohort study.
Yuliya Aleksandrovna Manuylova   +1 more
doaj   +1 more source

Endoscopic orbital decompression in Graves ophthalmopathy - Case report

open access: yes, 2018
Graves ophthalmopathy, an autoimmune disease, associated with hypermetabolism, enlargement of the thyroid gland and exophthalmia are the most frequent expressions of Graves’ disease, which often require surgical treatment.
Tatiana Decuseara   +5 more
core   +1 more source

Graves' Disease Presenting as Refractory Panic Attacks: Diagnostic Clarification Through Thyroid Scintigraphy

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Graves' disease may rarely present with predominant neuropsychiatric symptoms, such as severe, treatment‐resistant panic attacks, leading to misdiagnosis as a primary psychiatric disorder. We describe a 30‐year‐old woman with refractory panic attacks and night terrors who was initially treated with anxiolytics and antidepressants.
Mahsa Satari Gholami
wiley   +1 more source

Evaluation of Galectin-3 in Graves’ Disease With and Without Ophthalmopathy

open access: yesEndocrinology Research and Practice, 2023
Objective: There is a link between thyroid-associated ophthalmopathy and Graves’ disease; however, the exact pathophysiological mechanism remains unclear.
Muhammed Akın   +4 more
doaj  

Graves' ophthalmopathy [PDF]

open access: yes, 2009
A 40-year-old woman who recently received a diagnosis of Graves' disease comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg daily, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms ...
TANDA, MARIA LAURA PIERA   +1 more
core   +1 more source

Trends of Eye and Adnexa‐Related Hospital Admissions in Lebanon: An Epidemiological Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aim Visual impairment represents a major public health concern, affecting millions of individuals worldwide. In recent years, the global burden of eye diseases and vision impairment has continued to grow. This study aims to investigate the trends in eye and adnexa‐related hospital admissions in Lebanon from 2006 to 2019, as ...
Dany Akiki   +5 more
wiley   +1 more source

Modified Deep Lateral Wall Decompression Surgery in the Treatment of Thyroid‐Associated Ophthalmopathy: A Retrospective Evaluation

open access: yesEye &ENT Research, Volume 3, Issue 1, Page 5-10, March 2026.
ABSTRACT Background Thyroid‐associated ophthalmopathy (TAO) may lead to severe exophthalmos and dysthyroid optic neuropathy (DON), which can threaten visual function. Orbital decompression surgery is often required when medical therapy is insufficient; however, traditional deep lateral wall decompression techniques remain associated with several ...
Shuo Wu   +4 more
wiley   +1 more source

Improvement Of Graves' Ophthalmopathy After Administration Of The Cyclooxygenase-2 Selective Inhibitor Celecoxib: A Case-Report [PDF]

open access: yes, 2021
Graves' ophthalmopathy (GO) is a disabling complication of GravesBasedow disease, which in severe cases can progress toward blindness. Its treatment consists of the administration of corticosteroids, radiotherapy, as well as surgical treatment.
Roman, Deiana   +4 more
core   +1 more source

Retinal Capillary Density Reduction Contributes to Dysthyroid Optic Neuropathy via an L‐Arginine‐NO Pathway: A Metabonomics and Clinical Trial Study

open access: yesMedComm, Volume 7, Issue 3, March 2026.
Oxidative stress induces endothelial nitric oxide synthase (eNOS) uncoupling and L‐arginine depletion, reducing nitric oxide (NO) bioavailability in vascular endothelium and contributing to decreased retinal capillary density (RCD) in dysthyroid optic neuropathy (DON).
Yunhai Tu   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy